|
维百奥生物提供多达1000+各类抗体药物研发用对照品 药物对照抗体（Antibody Drug Reference Antibodies）列表
| Enapotamab | Mirvetuximab | Atezolizumab | Mogamulizumab | Dupilumab | Tomaralimab | Guselkumab | | Inebilizumab | Codrituzumab | Durvalumab | Talacotuzumab | Mepolizumab | Itolizumab | Eculizumab | | Tafasitamab | Disitamab | Crizanlizumab | Basiliximab | Benralizumab | Garadacimab | Cetuximab | | Rituximab | Trastuzumab | Elotuzumab | Belantamab | Narsoplimab | Burosumab | Avelumab | | Obinutuzumab | Pertuzumab | Tiragolumab | Alemtuzumab | Amatuximab | Anifrolumab | Sutimlimab | | Brentuximab | Brodalumab | Adalimumab | Lorvotuzumab | Anetumab | Orticumab | Ustekinumab | | Daratumumab | Sarilumab | Infliximab | Polatuzumab | Tanezumab | Vedolizumab | Tisotumab | | Vorsetuzumab | Tocilizumab | Urelumab | Cabiralizumab | Oxelumab | Canakinumab | Teplizumab | | Pamrevlumab | Enfortumab | Bimagrumab | Volagidemab | Alirocumab | Abituzumab | Tigatuzumab | | Ipilimumab | Camrelizumab | Cinpanemab | Vopratelimab | Olaratumab | Tarextumab | Nivolumab | | Ulocuplumab | Pembrolizumab | Evinacumab | Xentuzumab | Romosozumab | Blinatumomab | Belimumab | | More.. |
|
|
|
|
|
|
|
收缩
